Heart risks in rheumatoid arthritis: comparing two patient groups
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study compares heart health risks between two types of rheumatoid arthritis (RA): seronegative (without certain antibodies) and seropositive (with them). It aims to understand if heart risks differ between these groups, which could lead to better heart monitoring for RA patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a confirmed diagnosis of rheumatoid arthritis (RA) for at least 6 months.
- You must not have other autoimmune diseases like lupus or scleroderma.
- You must not be taking certain heart-affecting medications (like specific blood thinners or anti-inflammatories) beyond standard RA treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special heart CT scan to look for early signs of heart disease in people with rheumatoid arthritis. It may help find problems before symptoms start.
This study compares two treatment approaches for people with active rheumatoid arthritis who also have heart disease risk factors. It tests whether a newer drug called tofacitinib, combined with cholesterol medication, can better protect the heart than traditional TNF-inhibitor treatments.
This study looks at a protein called asprosin in the blood of people with rheumatoid arthritis to see if it relates to metabolic problems (like high blood sugar or cholesterol) and heart risk. By joining, you may help doctors understand how to better protect the heart health of people with rheumatoid arthritis.
This study looks at people with early arthritis related to rheumatoid arthritis, psoriatic arthritis, or psoriasis. Researchers want to understand how these early conditions behave and may help guide better treatment decisions.
This study looks at how to better manage health conditions like heart disease or diabetes in people with rheumatoid arthritis. Participants will work with their rheumatology clinic to improve overall health.
This study looks at lung health in people with early rheumatoid arthritis (RA). It may help doctors understand how RA affects the lungs soon after diagnosis and guide better care.
Hear when a new Rheumatoid arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.